Work

Does neoadjuvant systemic therapy in clinical T1–2 N0 human epidermal growth factor receptor 2–positive breast cancer increase the extent of axillary surgery?

Year: 2025

Type: article

Study design: Observational Study

Source: Surgery

DOI: 10.1016/j.surg.2025.109907

Authors: Christine C. Rogers, Lauren N. Cohen, Jan Irene C. Lloren, Chiang-Ching Huang, Adrienne N. Cobb, Amanda L. Kong, Puneet Singh, Mediget Teshome, Chandler S. Cortina

Institutions: Medical College of Wisconsin, University of Wisconsin–Milwaukee, Medical College of Wisconsin Cancer Center, The University of Texas MD Anderson Cancer Center, University of California, Los Angeles

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Award: Understanding the Influence of Hormone Therapy on Breast Cancer Risk and Screening through Mixed Methods

OpenAlex ID: W4417261777

FWCI:

Cites: 32

Cited by:

Related to: 10